Evolocumab公司
家族性高胆固醇血症
可欣
前蛋白转化酶
医学
PCSK9
单克隆抗体
单克隆
杂合子优势
内科学
内分泌学
阿利罗库单抗
低密度脂蛋白受体
脂蛋白
胆固醇
抗体
遗传学
免疫学
生物
等位基因
基因
载脂蛋白A1
作者
Raúl D. Santos,Andrea Ruzza,G. Kees Hovingh,Albert Wiegman,François Mach,Kurt Huber,Andrew Hamer,Ian Bridges,Andrea Bartuli,Jean Bergeron,T Szamosi,Saikat Santra,Claudia Stefanutti,Olivier Descamps,Susanne Greber‐Platzer,Ilse K. Luirink,John J.P. Kastelein,Daniel Gaudet
标识
DOI:10.1056/nejmoa2019910
摘要
Evolocumab, a fully human monoclonal antibody directed against proprotein convertase subtilisin–kexin type 9, is widely used in adult patients to lower low-density lipoprotein (LDL) cholesterol levels. Its effects in pediatric patients with heterozygous familial hypercholesterolemia are not known.
科研通智能强力驱动
Strongly Powered by AbleSci AI